SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-15-109391
Filing Date
2015-03-27
Accepted
2015-03-27 16:06:52
Documents
2
Effectiveness Date
2015-03-27

Document Format Files

Seq Description Document Type Size
1 DEFA14A d900402ddefa14a.htm DEFA14A 26617
2 GRAPHIC g900402g83c12.jpg GRAPHIC 13113
  Complete submission text file 0001193125-15-109391.txt   45976
Mailing Address 887 GREAT NORTHERN WAY SUITE 450 VANCOUVER A1 V5T 4T5
Business Address 887 GREAT NORTHERN WAY SUITE 450 VANCOUVER A1 V5T 4T5 604-629-9223
AQUINOX PHARMACEUTICALS, INC (Filer) CIK: 0001404644 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36327 | Film No.: 15731013
SIC: 2834 Pharmaceutical Preparations